Parvovirus B19 is a widespread infection that may affects 1–5% of pregnant women, mainly
with normal pregnancy outcome. The prevalence of infection is higher during epidemics …

Human parvovirus B19 is a single-stranded DNA virus with a predilection for infecting
rapidly dividing cell lines, such as bone marrow erythroid progenitor cells. People with …

Sickle cell disease (SCD)[1] is most commonly seen in individuals whose genetic origins are
in sub-Saharan Africa, southern India, and the Mediterranean. Approximately 1 in 350 …

Since the first evidence of human parvovirus B19 (B19V) infection in late 80s, several
studies have been conducted to clarify the spectrum of clinical diseases in Brazil. B19V …

Parvovirus B19 infection causes transient aplastic crisis in sickle cell disease (SCD) due to a
temporary interruption in the red blood cell production. Toxicity from hydroxyurea includes …

Abstract Human Parvovirus B19 (B19V) is a recognized cause of life‐threatening conditions
among patients with hemoglobinopathies. This study investigates B19V infection in patients …

Background. Parvovirus B19 (B19 V) infection had been reported to be more frequent with
serious clinical outcomes in patients with sickle cell disease (SCD) than in the general …

Human parvovirus B19 infection was studied in 60 thalassemic patients in Thailand.
Seroprevalence, persistence of parvovirus B19 and their genotypes were identified in blood …

Clinical, biochemical and molecular evidence for the sickle cell anemia (SCA) crisis in
Nigerian patients arising from parvovirus b19 infection remains inadequate. This study …

Abstract Parvovirus-B19 (PV-B19) is a member of Parvoviridae, which is one of the smallest
DNA viruses. PV-B19-associated diseases usually serve as a good representation of the …